Organized around accelerating progress in human health and scientific research, the core effort of Split Biosciences is an approach to single cell sequencing that was published in Science in 2018. Single-cell sequencing has enabled groundbreaking discoveries which have supported new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. With the emphasis is on providing researchers with the tools they need for single cell sequencing, Split Bioscience is developing a new method of sequencing cells RNA, the messenger molecules that communicate genetic instructions to proteins. The firm is developing a family of kits that enable researchers to perform scalable single-cell sequencing experiments. Unlike existing single cell technologies, Split Bios kits use only standard molecular biology equipment with no requirement for custom instrument..
